Jilin, China

Zhe Lin

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Changzhou Deze Medical Science Co., Ltd, Other. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhe Lin. Retrieved from https://idiyas.com/inventor/zhe-lin-eybxvl11

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 2 
 
Changzhou Deze Medical Science Co., Ltd
 patents
silverMedal1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhe Lin: Innovator in Medical Science

Introduction

Zhe Lin is a prominent inventor based in Jilin, China. He has made significant contributions to the field of medical science, particularly in the development of innovative treatments for various diseases. His work focuses on the intersection of pharmacology and therapeutic applications.

Latest Patents

Zhe Lin holds a patent for a compound known as mangiferin-6-O-berberine salt. This invention includes a preparation method and outlines its use as an AMPK activator for the treatment of diabetes and other related diseases. The patent highlights the potential of this compound in advancing medical treatments.

Career Highlights

Throughout his career, Zhe Lin has worked with various organizations, including Changzhou Deze Medical Science Co., Ltd. His expertise in the field has allowed him to contribute to significant advancements in medical research and development.

Collaborations

Zhe Lin has collaborated with notable colleagues such as Houlei Teng and Wei Wu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Zhe Lin's contributions to medical science through his innovative patent and collaborations with esteemed colleagues underscore his role as a key figure in the field. His work continues to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…